NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News $177.20 -0.74 (-0.42%) (As of 10/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends About VanEck Biotech ETF (NASDAQ:BBH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VanEck Biotech ETF alerts:Sign Up Key Stats Today's Range$177.20▼$178.6750-Day Range$173.33▼$182.7252-Week Range$142.51▼$183.64Volume4,400 shsAverage Volume6,857 shsMarket Capitalization$451.86 millionAssets Under Management$453.20 millionDividend Yield0.40%Net Expense Ratio0.35%Aggregate RatingModerate Buy ETF OverviewThe BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More… These LIVE trade signals would have dished out how much money? (Ad)51 LIVE trade signals…and you won’t believe how much some of my members could have grown their account! Seriously, for the first “beta testers” of this weekly income strategy…. The returns were JAW-DROPPING. How much could they have grown their $10k starting account?You’ll have to click here to find out. VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.55%0.49%0.52%Other Expenses0.00%0.33%0.49%0.41%0.54%Total Expense0.35%0.71%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.52%-0.32%-0.57%Net Expense0.35%0.61%0.61%0.56%0.59% Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address BBH ETF News HeadlinesAre Rate Cuts Bad News For BIZD ETF?September 10, 2024 | seekingalpha.comEmphasize Consistency To Navigate VolatilitySeptember 7, 2024 | seekingalpha.comThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…October 18, 2024 | WealthPress (Ad)VanEck Fabless Semiconductor ETF (NASDAQ:SMHX) Quotes, Forecast and News SummaryAugust 29, 2024 | benzinga.com3 Biotech ETFs for a Diversified PortfolioAugust 15, 2024 | stocknews.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 29, 2024 | benzinga.comSee More Headlines BBH ETF - Frequently Asked Questions How have BBH shares performed this year? VanEck Biotech ETF's stock was trading at $165.31 at the beginning of 2024. Since then, BBH stock has increased by 7.2% and is now trading at $177.20. View the best growth stocks for 2024 here. Who are VanEck Biotech ETF's major shareholders? Top institutional investors of VanEck Biotech ETF include Pacific Sun Financial Corp (0.22%) and Creative Planning (0.07%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ). Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$453.20 million Average Daily Volume$3,652.70 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest700 shs Miscellaneous Outstanding Shares2,550,000Beta0.85 Creation Unit50,000 Creation Fee$500.00 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Top 10 BBH HoldingsAmgen (NASDAQ:AMGN)Holding Weight: 16.82%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 9.87%Gilead Sciences (NASDAQ:GILD)Holding Weight: 9.38%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 8.42%IQVIA (NYSE:IQV)Holding Weight: 4.93%argenx (NASDAQ:ARGX)Holding Weight: 4.68%ICON Public (NASDAQ:ICLR)Holding Weight: 4.65%Biogen (NASDAQ:BIIB)Holding Weight: 4.12%Illumina (NASDAQ:ILMN)Holding Weight: 3.91%Moderna (NASDAQ:MRNA)Holding Weight: 3.56%Full Holdings DetailsBBH Sector ExposureBBH Industry Exposure This page (NASDAQ:BBH) was last updated on 10/18/2024 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredDon’t Buy Another Stock Until Reading This…Buying stocks in today's market is a gamble… Unless you're using the right proven strategy! During my up...Unstoppable Prosperity | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
